PATENT CLAIM ANALYSIS

Application Number: 16045594
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "365000"]

Abstract:
[Problem] Provided is a novel 1,3,4,8-tetrahydro-2H-pyrido[1,2-a]pyrazine derivative or a pharmaceutically acceptable salt thereof, or a solvate thereof, which is useful as an anti-HIV agent. [Solving Means] The present invention provides a compound represented by the following formula [I] wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof, or a solvate thereof.

Claim (Index 16):
The compound according to  claim 13 , wherein R 41  is a C 1-6  alkyl group optionally substituted by the same or different 1 to 5 substituents selected from group A, and\n R 21 , R 31  and R 51  are each a hydrogen atom, or a pharmaceutically acceptable salt thereof, or a solvate thereof.

Metadata:
- Claim Count in Document: 99.0
- Percentile: 95.0
- Lexical Diversity: 1.65909
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13034866', '11767021', '12576605', '12837679', '11736064']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7947769849911753
- 35 USC 102 Novelty (BERT): 0.5723495046093025
- Combined Prediction Score: 0.772534236952988
- Mean Citation Score: 390.11279
- Max Citation Score: 444.2332
- Similarity Product: 399.6242560904503

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test